In Brief: BSE
This article was originally published in The Rose Sheet
Executive Summary
BSE: FDA's Transmissible Spongiform Encephalopathies Advisory Committee to meet April 23 from 8 a.m. to 6 p.m., and April 24 from 8 a.m. to 5 p.m. to discuss and provide recommendations on the potential risk of gelatin and gelatin by-products with regard to the transmission of bovine spongiform encephalopathy. The meeting will be held at the Holiday Inn in Bethesda, Md. in Versailles Ballrooms III and IV. The public portion of the meeting will be held from 9 a.m. to 10 a.m. April 23 with open committee discussion to follow the rest of that day and on April 24...